diphenhydramine hydrochloride has been researched along with Prostatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barken, I; Geller, J; Rogosnitzky, M | 1 |
| Abdalla, MO; Aneja, R; Karna, P; Mao, H; Sajja, HK; Turner, T; Yates, C | 1 |
2 other study(ies) available for diphenhydramine hydrochloride and Prostatic Neoplasms
| Article | Year |
|---|---|
Prophylactic noscapine therapy inhibits human prostate cancer progression and metastasis in a mouse model.
Topics: Animals; Antitussive Agents; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Humans; Lymphatic Metastasis; Male; Mice; Mice, Nude; Noscapine; Prostatic Neoplasms; Xenograft Model Antitumor Assays | 2010 |
Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy.
Topics: Antineoplastic Agents; Antitussive Agents; Cell Line; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Gene Expression Regulation, Neoplastic; Humans; Magnetic Resonance Imaging; Male; Nanoparticles; Noscapine; Prostate; Prostatic Neoplasms; Receptors, Urokinase Plasminogen Activator | 2011 |